Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Jun;38(1):60-64.
doi: 10.4103/0253-7184.203438.

Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department

Johnathan Michael Sheele  1 , Nathan Morris  2 , Donald Byars  3 , Frank Counselman  3
Affiliations

Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department

Johnathan Michael Sheele et al. Indian J Sex Transm Dis AIDS. 2017 Jan-Jun.

Abstract

Background: Proton pump inhibitors (PPIs) have been shown in cell culture to kill Trichomonas vaginalis (TV) at lower half maximal inhibitory concentration values than metronidazole (Flagyl), the most common medication used to treat the infection. However, there have been no previous clinical investigations to determine if PPIs are associated with reduced risk for TV.

Materials and methods: We examined the records of female patients who received testing in the emergency department for TV, Neisseria gonorrhoea (GC), and Chlamydia trachomatis (CT) between 2010 and 2014 at two academic medical centers to determine if PPI and histamine type 2 receptor antagonist (H2RA) drugs were associated with TV and GC/CT infections.

Results: We found that H2RAs were associated with an increased likelihood for TV (odds ratio [OR]: 2.0, P < 0.0001) and GC and/or CT infections (OR: 1.49, P < 0.0001). PPIs were associated with a reduced likelihood for TV (OR: 0.75, P < 0.0001) and GC and/or CT infections (OR: 0.57, P < 0.0001). In patients infected with GC and/or CT, the likelihood of coinfection with TV was reduced in those taking a PPI (OR: 0.64, P = 0.054) and increased in those taking an H2RA (OR: 1.62, P = 0.003).

Conclusions: PPIs are associated with a reduced risk for TV and GC/CT infection.

Keywords: Chlamydia trachomatis; Neisseria gonorrhoea; Trichomonas vaginalis; histamine type-2 receptor antagonist; proton pump inhibitor; sexually transmitted disease.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

References

    1. Coleman JS, Gaydos CA, Witter F. Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: New concepts and controversies. Obstet Gynecol Surv. 2013;68:43–50. - PMC - PubMed
    1. Nielsen TJ, Pradhan P, Brittingham A, Wilson WA. Glycogen accumulation and degradation by the trichomonads Trichomonas vaginalis and Trichomonas tenax. J Eukaryot Microbiol. 2012;59:359–66. - PubMed
    1. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Morb Mortal Wkly Rep. 2010;59:58–61.
    1. Weinstock H, Berman S, Cates W., Jr Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6–10. - PubMed
    1. Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev. 2004;17:783–93. - PMC - PubMed